Sam is Managing Partner, Life Sciences, at IP Group plc. He has 20 years’ experience in the biotech sector, both as a top-ranked equity analyst in the City of London and, subsequently, as a chief executive and non-executive director. He currently serves as Executive Chairman of Istesso Ltd, Chairman of Glythera Ltd and Microbiotica Ltd, and as a director of Diurnal Group plc.

Sam has a PhD in molecular biology from Cambridge and a degree in biology from Oxford.